Full Year
BMRA — FY2026 Annual Financial Report Analysis
Biomerica's FY2026 sales fell 16% to $4.45M and its operating loss widened to $5.32M; the smaller $3.78M net loss came from a one-off $1.1M COVID tax refund and a paper gain, with going-concern doubt and heavy share dilution continuing.